Literature DB >> 10652491

Schistosome population genetic structure: when clumping worms is not just splitting hairs.

J Curtis1, D J Minchella.   

Abstract

Schistosomiasis is a major public health problem, affecting over 200 million people worldwide. Although Schistosoma mansoni has been studied rigorously in an attempt to provide a vaccine based on a number of candidate antigens, there has been a lack of complementary effort to determine the range and distribution of variation in representative molecules throughout natural populations. Here, Jason Curtis and Dennis Minchella highlight current (and suggest future) research efforts aimed at assessing genetic variation in schistosome populations, and call for a more robust consideration of schistosome population genetics.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10652491     DOI: 10.1016/s0169-4758(99)01553-7

Source DB:  PubMed          Journal:  Parasitol Today        ISSN: 0169-4758


  12 in total

1.  Genetic diversity and population structure of Schistosoma mansoni within human infrapopulations in Mwea, central Kenya assessed by microsatellite markers.

Authors:  L E Agola; M L Steinauer; D N Mburu; B N Mungai; I N Mwangi; G N Magoma; E S Loker; G M Mkoji
Journal:  Acta Trop       Date:  2009-05-07       Impact factor: 3.112

2.  Inbreeding within human Schistosoma mansoni: do host-specific factors shape the genetic composition of parasite populations?

Authors:  F Van den Broeck; L Meurs; J A M Raeymaekers; N Boon; T N Dieye; F A M Volckaert; K Polman; T Huyse
Journal:  Heredity (Edinb)       Date:  2014-03-12       Impact factor: 3.821

3.  Genetic consequences of mass human chemotherapy for Schistosoma mansoni: population structure pre- and post-praziquantel treatment in Tanzania.

Authors:  Alice J Norton; Charlotte M Gower; Poppy H L Lamberton; Bonnie L Webster; Nicholas J S Lwambo; Lynsey Blair; Alan Fenwick; Joanne P Webster
Journal:  Am J Trop Med Hyg       Date:  2010-10       Impact factor: 2.345

4.  Development and application of an ethically and epidemiologically advantageous assay for the multi-locus microsatellite analysis of Schistosoma mansoni.

Authors:  C M Gower; J Shrivastava; P H L Lamberton; D Rollinson; B L Webster; A Emery; N B Kabatereine; J P Webster
Journal:  Parasitology       Date:  2006-11-13       Impact factor: 3.234

Review 5.  Brazilian studies on the genetics of Schistosoma mansoni.

Authors:  Rosana Gentile; Guilherme Oliveira
Journal:  Acta Trop       Date:  2008-09-11       Impact factor: 3.112

6.  Molecular epidemiology of Schistosoma mansoni: a robust, high-throughput method to assess multiple microsatellite markers from individual miracidia.

Authors:  Michelle L Steinauer; Lelo E Agola; Ibrahim N Mwangi; Gerald M Mkoji; Eric S Loker
Journal:  Infect Genet Evol       Date:  2008-01       Impact factor: 3.342

7.  Diversification of Schistosoma japonicum in Mainland China revealed by mitochondrial DNA.

Authors:  Qin Ping Zhao; Ming Sen Jiang; Hui Fen Dong; Pin Nie
Journal:  PLoS Negl Trop Dis       Date:  2012-02-14

8.  Geographic strain differentiation of Schistosoma japonicum in the Philippines using microsatellite markers.

Authors:  Kharleezelle J Moendeg; Jose Ma M Angeles; Ryo Nakao; Lydia R Leonardo; Ian Kendrich C Fontanilla; Yasuyuki Goto; Masashi Kirinoki; Elena A Villacorte; Pilarita T Rivera; Noboru Inoue; Yuichi Chigusa; Shin-Ichiro Kawazu
Journal:  PLoS Negl Trop Dis       Date:  2017-07-10

9.  Population genetics of Schistosoma japonicum within the Philippines suggest high levels of transmission between humans and dogs.

Authors:  James W Rudge; Hélène Carabin; Ernesto Balolong; Veronica Tallo; Jaya Shrivastava; Da-Bing Lu; María-Gloria Basáñez; Remigio Olveda; Stephen T McGarvey; Joanne P Webster
Journal:  PLoS Negl Trop Dis       Date:  2008-11-25

10.  Genetic diversity of Schistosoma haematobium parasite IS NOT associated with severity of disease in an endemic area in Sudan.

Authors:  Nagla Gasmelseed; Nhashal E Karamino; Mohammed O Abdelwahed; Anas O Hamdoun; Ahmed E Elmadani
Journal:  BMC Infect Dis       Date:  2014-08-27       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.